Activated platelets correlate with mobilization of naïve CD34(+) cells and generation of CD34(+) /KDR(+) cells in the circulation. A meta-regression analysis

J Thromb Haemost. 2013 Aug;11(8):1583-92. doi: 10.1111/jth.12315.

Abstract

Background: Bone marrow-derived circulating CD34(+) progenitor cells participate in remodeling and repair of the vasculature. Coexpression of the kinase-insert domain-containing receptor (KDR) has been proposed to identify the regenerative capacity. Recently, we provided evidence that the major fraction of circulating CD34(+) /KDR(+) cells is not mobilized from bone marrow, but is generated at sites of vascular injury through interaction with platelets.

Objectives: To determine the relationship between platelet activation, the recruitment of naïve CD34(+) cells and the generation of CD34(+) /KDR(+) progenitor cells in a broad range of (patho)physiologic conditions, a detailed meta-regression analysis was conducted.

Methods/results: Twenty-eight conditions were found in which the numbers of CD34(+) and/or CD34(+) /KDR(+) cells and the levels of soluble P-selectin, as a marker for in vivo platelet activation, were documented. To combine heterogeneous data from 214 selected articles, results were standardized to a uniform scale by calculating standardized mean differences (SMDs) obtained from patient and control cohorts. Subsequently, a random-effects meta-regression analysis was performed on pooled SMDs.

Conclusions: Our systemic survey supports a model in which activated platelets are a determinant for mobilization of CD34(+) cells from the bone marrow and the generation of CD34(+) /KDR(+) cells in the circulation.

Keywords: aspirin; circulation; platelets; stem cells; vasculature.

Publication types

  • Meta-Analysis
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antigens, CD34 / blood*
  • Aspirin / chemistry
  • Blood Platelets / cytology
  • Cohort Studies
  • Gene Expression Regulation
  • Hematopoietic Stem Cell Mobilization*
  • Humans
  • P-Selectin / blood
  • Platelet Activation*
  • Platelet Aggregation Inhibitors / chemistry
  • Regression Analysis
  • Stem Cells / cytology*
  • Vascular Endothelial Growth Factor Receptor-2 / blood*

Substances

  • Antigens, CD34
  • P-Selectin
  • Platelet Aggregation Inhibitors
  • Vascular Endothelial Growth Factor Receptor-2
  • Aspirin